Skip to main content
Tulane Home Tulane Home

Prostate Cancer Symposium 2019 ~ Overview

The symposium will address prostate cancer diagnosis and treatment, including: screening and surveillance, focal therapy, recurrent and locally advanced disease, surgery, rehabilitation, radiation, genetics, metastatic cancer, and castrate-resistant prostate cancer. Through lectures and speaker panels, attendees will gain the latest knowledge in prostate cancer treatment from world-renowned experts in oncology and urology.

STATEMENT OF NEED
Prostate cancer has the highest rates of incidence, and is the second most deadly cancer in the United States. Louisiana, specifically, saw some of the highest morbidity and mortality rates in the country. Treatment requires the expertise of several different specialty practitioners including: urologists, radiation oncologists, and medical oncologists. New findings in the treatment of prostate cancer at the various stages of development require continued education. Advanced disease progression requires highly technical and specialized treatment, requiring practitioners to be knowledgeable in the latest and most effective treatment methods.

INTENDED AUDIENCE
Physicians (and other healthcare providers) specializing in urology, medical oncology, radiation oncology, and relevant surgical sub-specialties.

Educational Objectives (learner perspective, short-term, generally achievable immediately, and defined in measurable terms)

  • Describe therapeutic options for patients with prostate cancer and how to tailor therapy for individual patients.
  • Apply data from new biomarkers and address how they are relevant for current practice.
  • Apply recent data with emerging therapies for the treatment of patients with prostate cancer and integrate key findings into clinical practice.

Predicted Outcomes (self-reported, longer-term objectives as a result of implementation of increased knowledge, improved competence or performance; measured 3-4 months post-activity)

  • Decrease prevalence of fatal prostate cancer through the utilization of the most current research-based therapeutic options in conjunction with existing agents.
  • Improve patient care by providing individual treatment based on the patient’s unique needs with sensitivity toward quality of life considerations.
  • Increase positive prostate cancer patient outcomes by integrating new discovered diagnosis and treatment therapies into daily clinical practice.